Jade Biosciences (JBIO) Non-Current Assets (2020 - 2026)

Jade Biosciences has reported Non-Current Assets for 7 years, with the latest figure at $916000.0 in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets rose 472.5% year-over-year to $916000.0; the trailing twelve-month figure through Mar 2026 stood at $4.0 million (down 13.89% YoY), and the FY2025 full-year result was $965000.0, down 69.32% from the prior year.
• Non-Current Assets for Q1 2026 stood at $916000.0, down from $965000.0 in the prior quarter.
• The five-year high for Non-Current Assets was $3.8 million in Q1 2023, with the low at $160000.0 in Q1 2025.
• Historically, Non-Current Assets has averaged $2.1 million across 5 years, with a median of $2.2 million in 2022.
• Annual changes were most pronounced in 2025 — Non-Current Assets plunged 95.53% — and 2026, when it jumped 472.5%.
• Jade Biosciences' Non-Current Assets stood at $3.8 million in 2022, then retreated by 16.27% to $3.2 million in 2023, then declined by 1.29% to $3.1 million in 2024, then slumped by 69.32% to $965000.0 in 2025, then retreated by 5.08% to $916000.0 in 2026.
• The last three Non-Current Assets figures came in at $916000.0 (Q1 2026), $965000.0 (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.